drugset / Trial / NCT01921985

Terlipressin Administration in Patients Undergoing Major Liver Resection

NCT01921985

Phase 2 Terminated 150 enrolled Insel Gruppe AG, University Hospital Bern
RandomizedParallel-groupDouble-blindTreatment

Summary

This study investigates if the administration of terlipressin reduces complications after major liver surgery.

Timeline

Start
2013-11
Primary completion
2018-03
Completion
2018-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Terlipressin Peptide 1 mg Intravenous

Indications